USANA Health Sciences: That Jim Brown Stepped Down As The Company’s Chief Executive Officer And President, And That Kevin Guest, The Company’s Chairman Of The Board, Reassumed The Role Of Chief Executive Officer. At The Time Of The Initial 8k, The Compensation Committee Of The Board (the “compensation Committee”) Had Not Determined The Compensation Arrangements For Mr. Brown Or Mr. Guest. The Compensation Committee Has Now Determined These Arrangements And, In Accordance With Instruction 2 To Item 5.02 Of Form 8k, The Company Is Filing This Amendment No. 1 To (i) Disclose The Material Terms Of The Transition Agreement Entered Into Between The Company And Mr. Brown And File Such Agreement As An Exhibit Hereto, And (ii) To Disclose The Material Terms Of Mr. Guest’s Compensation In Connection With His Appointment As Chief Executive Officer. Except As Specifically Set Forth Herein, No Other Changes Are Being Made To The Initial Form 8k, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  USANA Health Sciences, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***